Publications Database

Erickson C. A. et al. (2005)

Gastrointestinal factors in autistic disorder: a critical review.

Journal of Autism and Developmental Disorders

35(6), pp. 713-727

Read Abstract (New Window)

Farmer C. A. et al. (2012)

Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.

Journal of Autism and Developmental Disorders

June, 4(6), pp. 1037-1044.

Read Abstract (New Window)

Kowalski J. et al. (2011)

Paliperidone palmitate in a child with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

October, 21(5), pp. 491-493

McDougle C. J. et al. (2008)

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Journal of Clinical Psychiatry

69 pp.15-20

Read Abstract (New Window)

McDougle C. J. , Stigler K. A. , Posey D. J. (2003)

Treatment of aggression in children and adolescents with autism and conduct disorder.

Journal of Clinical Psychiatry

64 pp. 16-25

Read Abstract (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Posey D. J. et al. (2008)

Antipsychotics in the treatment of autism.

Journal of Clinical Investigation

118(1), pp. 6-14

Read Abstract (New Window) Read Full (New Window)

Posey D. J. et al. (2006)

The use of selective serotonin reuptake inhibitors in autism and related disorders.

Journal of Child and Adolescent Psychopharmacology

16(1), pp. 181-186

Read Abstract (New Window)

Scahill L. et al. (2012)

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Journal of the American Academy of Child and Adolescent Psychiatry

51(2), pp. 136-146

Read Abstract (New Window)

Stigler K. A. et al. (2004)

A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 49-56

Read Abstract (New Window)

Stigler K. A. et al. (2009)

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Journal of Child and Adolescent Psychopharmacology

19(3), pp. 265-274

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. et al. (2009)

Autism and immune factors: A comprehensive review.

Research in Autism Spectrum Disorders

pp. 840-860

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2004)

Case report: aripiprazole for maladaptive behavior in pervasive developmental disorder.

Journal of Child and Adolescent Psychopharmacology

14(3), pp. 455-463

Read Abstract (New Window)

Stigler K. A. et al. (2010)

Paliperidone for irritability in autistic disorder.

Journal of Child and Adolescent Psychopharmacology

pp. 75-78

Read Extract (New Window)

Stigler K. A. , McDougle C. J. (2008)

Pharmacotherapy of irritability in pervasive developmental disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 739-752

Read Abstract (New Window)

Stigler K. A. (2014)

Psychopharmacologic management of serious behavioral disturbance in ASD.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 73-82.

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2006)

Ramelteon for insomnia in two youths with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 631-636

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2002)

Recent advances in the pharmacotherapy of autism.

Expert Review of Neurotherapeutics

2(4), pp. 499-510

Read Abstract (New Window)

Stigler K. A. et al. (2004)

Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Pediatric Drugs

6(1), pp. 33-44

Read Abstract (New Window)

Wink L. K. et al. (2010)

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Expert Opinion on Emerging Drugs

September, 15(3), pp. 481-494

Read Abstract (New Window)